Wardyn, Pierre-Marie
Edme, Jean-Louis
de Broucker, Virginie
Cherot-Kornobis, Nathalie
Ringeval, David
Amouyel, Philippe
Sobaszek, Annie
Dauchet, Luc
Hulo, Sébastien
Funding for this research was provided by:
European Regional Development Fund (ERDF-FEDER Presage N°36034, ERDF-FEDER Presage N°36034)
Agence Nationale de la Recherche (I-SITE ULNE / ANR-16-IDEX-0004 ULNE, I-SITE ULNE / ANR-16-IDEX-0004 ULNE)
Article History
Received: 14 November 2023
Accepted: 17 January 2024
First Online: 31 January 2024
Declarations
:
: The study protocol was registered at ClinicalTrials.gov (identifier: NCT02490553) and had been approved by the local independent ethics committee (CPP Nord Ouest IV, Lille, France; reference: 2010-A00065-34), in compliance with the French legislation on biomedical research. All the participants gave their written, informed consent prior to inclusion in the study.
: Not applicable.
: The authors declare no competing interests.